期刊文献+

PTX3与慢性肾脏病患者肾功能及蛋白尿的相关性研究 被引量:2

Study on the correlation between Long Pentraxin 3 and renal function,proteinuria in chronic kidney disease
下载PDF
导出
摘要 目的探讨慢性肾脏病(CKD)患者血浆五聚素3(PTX3)水平与肾小球滤过率(GFR)、24 h尿蛋白定量的关系。方法将90例CKD患者分为CKD3期组(A组)、CKD4期组(B组)、CKD5期组(C组),每组30例,另选健康正常人15例为对照组。各组均常规检测尿素氮、肌酐、24 h尿蛋白定量等,用简化MDRD公式计算各组GFR,用放免法测定PTX3、高敏C反应蛋白(hs-CRP)、肿瘤坏死因子α(TNF-α)水平。结果 A、B、C 3组患者PTX3、hs-CRP、TNF-α水平均明显高于对照组;单变量分析显示,PTX3与CKD患者的GFR呈直线负相关(r=-0.69),PTX3与CKD患者的24 h尿蛋白定量呈直线正相关(r=0.46)。结论 CKD患者体内存在炎症状态,CKD患者的肾功能、尿蛋白与PTX3关系更为密切。 Objective It is to investigate the relations between plasma levels of Pentraxin 3 and glomerular filtration rate (GFR) , 24-hour proteinuria in patients with chronic kidney disease( CKD). Methods 90 patients with chronic kidney disease were divided into 3 groups : stage 3 CKD group ( group A) , stage 4 CKD group ( group B) and stage 5 CKD group ( group C) with 30 cases in each group, and 15 healthy people were chosen as control group. Plasma Pentraxin 3 (PTX3) , high-sensitive C- reactive protein (hs -CRP), Tumor necrosis factor-alpha (TNF-a), GFR, 24-hour proteinuria were studied. Results The levels of plasma PTX3, hs -CRP, TNF-a were significantly higher in chronic kidney disease than those in control group. Univariate analysis showed PTX3 was negatively correlated with GFR, and it was positively correlated with 24-hour proteinuria. Conclusion Chronic inflammation was existed in patients with chronic kidney disease, renal function, urinal protein of the patients with CKD were closely with plasma PTX3. Comparing with CRP ,Plasma PTX3 is more related to GFR and pro- teinuria . It increases as GFR delines and decreases when 24-hour proteinuria increases.
出处 《现代中西医结合杂志》 CAS 2013年第10期1037-1039,共3页 Modern Journal of Integrated Traditional Chinese and Western Medicine
关键词 慢性肾脏病 血浆五聚素3 超敏C反应蛋白 肿瘤坏死因子 24 h尿蛋白定量 chronic kidney disease Pentraxin 3 high-sensitive C - reactive protein tumor necrosis factor - ot 24-hourproteinuria
  • 相关文献

参考文献15

  • 1钱家麒,姚强.慢性肾衰竭透析患者中炎症发生的原因和后果[J].中国中西医结合肾病杂志,2005,6(8):435-437. 被引量:14
  • 2Mantovani A,Garlanda C,Doni A,et al.Pentraxins in innate immunity:from C-reative protein to the long pentraxin PTX3[J].J Clin Immuno,2008,128:1-13.
  • 3Breviario F,D'Aniello EM,Golay J,et al.Interleukin-1-inducible genes in endothelial cells.Cloning of a new gene related to C-realtive protein and serum amyloidp component[J].J Biol Chem,1992,267(31):22190-22197.
  • 4Yilmaz MI,Axelsson J,Sonmez A,et al.Effect of rennin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria[J].Clin J Am Nephrol,2009,4(3):535-541.
  • 5Garlanda C,Bottazzi B,Bastone A,et al.Pentraxins at the crossroads between innate immunity,inflammation,matrix deposition,and female fertility[J].Annual Rev Immunol,2005,23(8):337-366.
  • 6Tong M,Carrero JJ,Qureshi AR,et al.Plasma Pentraxin 3 in patients with chronic kidney disease:associations with renal function,protein-energy wasting cardiovascular disease,and mortality[J].Clin J Am Soc Nephrol,2007,2:889-897.
  • 7Suliman ME,Yilmaz MI,Carrero JJ,et al.Novel links between the long pentraxin 3,endothelial dysfunction,and albuminuria in early and advanced chronic kidney disease[J].Clin J Am Soc Nephrol,2008,3(4):976-985.
  • 8Muller B,Peri G,Doni A,et al.Circulating levels of the long pentraxin 3 PTX3 correlate with severity of infection in critically ill patients[J].Crit Care Med,2001,29:1404-1407.
  • 9Boehme M,Kaehne F,Kuehne A,et al.Pentraxin 3 is elevated in haemodialysis patients and is associated with cardiovascular disease[J].Nephol Dial Transplant,2007,22:2224-2229.
  • 10Savchenko A,Imamura M,Dhashi R,et al.Expression of pentraxin 3 (PTX3) in human atheroscler-otic lesions[J].J Pathol,2008,215(1):48-55.

二级参考文献35

  • 1Tintut Y, Patel J, Parhami F, et al. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation,2000,102(21) :2636 - 2642.
  • 2Ketteler M, Bongartz P,Westenfeld R,et al. Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross - sectional study. Lancet, 2003,361 (9360): 827 - 833.
  • 3Stenvinkel P. Malnutrition and chronic inflammation as risk factors for cardiovascular disease in chronic renal failure. Blood Purif,2001,19(2) :143 - 151.
  • 4Yao Q, Pecoits - Filho R, Lindholm B, et al. Traditional and non- traditional risk factors as contributors to atherosclerotic cardiovascular disease in end - stage renal disease. Scand J Urol Nephrol,2004,38(5):405-416.
  • 5Wang T, Heimburger O, Cheng HH, et al. Does a high peritoneal transport rate reflect a state of chronic inflammation? Perit Dial Int, 1999,19( 1 ): 17 - 22.
  • 6Ketteler M, Wanner C, Metzger T, et al. Deficiencies of calcim- regulatory proteins in dialysis patients: A novel concept of cardiovascular calcification in uremia. Kidney Int, 2003,63(Suppl 84): 84 - 87.
  • 7Cheung AK, Sarnak MJ, Yan G, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients.Kidney Int,2000,58(1) :353 - 362.
  • 8Stenvinkel P,Alvestrand A. Inflammation in end - stage renal disease: sources, consequences, and therapy. Semin Dial,2002,15 (5): 329 - 337.
  • 9Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med, 1999,340(2): 115 - 126.
  • 10Memoli B, Postiglione L, Cianciaruso B, et al. Role of different dialysis membranes in the release of interleukin -6 soluble receptor in uremic patients. Kidney Int, 2000, 58(1) :417 -424.

共引文献13

同被引文献29

  • 1Breviario F, dAniello EM, Golay J, et al. Interleukin - 1 -induc- ible genes in endothelial cells. Cloning of a new gene related to Cre- active protein and serum amyloid P component [ J ]. The Journal of Biological Chemistry, 1992,267 ( 31 ) :22190 - 22197.
  • 2Lee GW, Lee TH, Vilcek J. TSG - 14, a tumor necrosis factor - and IL - 1 - inducible protein, is a novel member of the pentaxin family of acute phase proteins [ J ]. The Journal of Immunology, 1993,150(5) :1804 - 1812.
  • 3Cecilia Garlanda, Barbara Bottazzi, Antonio Bastone, et al. Pentrax- ins at the crossroads between innate immunity, inflammation, ma- trix deposition, and female fertility [ J]. Annual Review of Immunol- ogy, 2005,23:337 - 366.
  • 4Inforzato A, Rivieccio V, Morrealc AP, et al. Structural character- ization of PTX3 disulfide bond network and its multimeric status in cumulus matrix organization [ J ]. The Journal of biological Chemis- try, 2008,283(15) :10147 - 10161.
  • 5Kenji Daigo, Takao Hamakubo. Host - protective effect of circulat- ing pentraxin 3 ( PTX3 ) and complex formation with neutrophil ex- tracellular traps [ J ]. Frontiers in hnmunology, 2012,3 ( 378 ) doi : 10. 3389/fimmu. 2012. 00378.eCollection 2012. 2012.
  • 6Cecilia Garlanda, Barbara Bottazzi, Federica Moalli, et al. Pen- traxins and Atherosclerosis: The Role of PTX3 [ J]. Current Phar- maceutical Design,2011, 17 ( 1 ) : 38 -46.
  • 7Bassi N, Ghirardello A, Blank M, et al. lgG anti - pentraxin 3 an- tibodies in systemic lupus erythematosus [ J]. Annals of the Rhea- matic Diseases ,2010 ;69(9 ) : 1704 - 1710.
  • 8Doria A, Gatto M. Nephritogenic - antinephritogenic antibody net- work in lupus glomemlonephritis[ J 1. Lupus, 2012,21 ( 14 ) : 1492 - 1496.
  • 9Yuki Shimada, Yu Funakubo Asanuma , Kazahiro Yokota, et al. Pentraxin 3 is associated with disease activity but not atherosclerosis in patients with systemic lupus erythematosus[ J]. Japan College of Rheumatology,2014, 24 ( 1 ) : 78 -85.
  • 10Tong M, Carrero J J, Qureshi AR, et al. Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal func- tion, proteinenergy wasting, cardiovascular disease,and mortality [ J ]. Clinical Journal of the American Society of Nephrology, 2007,2 (5) : 889 - 897.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部